We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
198 hedge funds and large institutions have $6.87B invested in Puma Biotechnology in 2015 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 86 increasing their positions, 56 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
54% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 56
50% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 20
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
34% more capital invested
Capital invested by funds: $5.13B → $6.87B (+$1.74B)
5% more funds holding
Funds holding: 188 → 198 (+10)
1.18% more ownership
Funds ownership: 90.06% → 91.23% (+1.2%)
13% less call options, than puts
Call options by funds: $56.3M | Put options by funds: $64.6M
Holders
198
Holders Change
+10
Holders Change %
+5.32%
% of All Funds
5.28%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.19%
New
30
Increased
86
Reduced
56
Closed
20
Calls
$56.3M
Puts
$64.6M
Net Calls
-$8.3M
Net Calls Change
+$4.31M
Top Buyers
Top Sellers
| 1 |
Wells Fargo
San Francisco,
California
|
-$32.2M |
| 2 |
FAM
Fred Alger Management
New York
|
-$24.1M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$17.8M |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$14.9M |
| 5 |
OH
Orbis Holdings
Hamilton,
Bermuda
|
-$12M |
